Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol

INTRODUCTION: Atenolol, a commonly prescribed β blocker for hypertension, is also associated with adverse cardiometabolic effects such as hyperglycemia and dyslipidemia. Knowledge of the mechanistic underpinnings of these adverse effects of atenolol is incomplete. OBJECTIVE: We sought to identify bi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Metabolomics
Main Authors: Weng, Liming, Gong, Yan, Culver, Jeffrey, Gardell, Stephen J., Petucci, Christopher, Morse, Alison M., Frye, Reginald F., Turner, Stephen T., Chapman, Arlene, Boerwinkle, Eric, Gums, John, Beitelshees, Amber L., Borum, Peggy R., Johnson, Julie A., Garrett, Timothy J., McIntyre, Lauren M., Cooper-DeHoff, Rhonda M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5313050/
https://ncbi.nlm.nih.gov/pubmed/28217401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1098-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados